U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2016, Business and Industry Statistics


U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2016


 

January

February

March

April

May

June


Standard

7

8

4

12

4

5


Priority

1

0

1

2

3

1


Standard (Orphan)

1

0

2

2

0

0




A Representative List of Organizations that Have Used our Research and Products: